Ardsley Advisory Partners’s T2 Biosystems, Inc TTOO Stock Holding History

Ardsley Advisory Partners’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-175	Closed	-$1.47M	–	185
2019 Q2	$1.47M	Buy	175 +10	+6%	+$117K	0.23%	56
2019 Q1	$2.17M	Buy	165 +23	+16%	+$391K	0.42%	47
2018 Q4	$2.13M	Sell	142 -45	-24%	-$1.06M	0.54%	37
2018 Q3	$6.97M	Buy	187 +36	+24%	+$1.19M	0.94%	33
2018 Q2	$5.84M	Buy	+151	New	+$5.73M	0.88%	45

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ardsley Advisory Partners's TTOO Position: Q3 2019 in Review

Ardsley Advisory Partners sold out of T2 Biosystems, Inc (TTOO) in Q3 2019, closing a stake of 175 shares — an estimated $1.47M sold.

Ardsley Advisory Partners first reported a position in TTOO in Q2 2018 and held it in 5 quarters. The position peaked at $6.97M in Q3 2018. 48 funds tracked by Wall St. Rank hold TTOO as of Q3 2019.

Ardsley Advisory Partners reported no remaining T2 Biosystems, Inc position as of Q3 2019 after selling out during the quarter.
Ardsley Advisory Partners sold 175 T2 Biosystems, Inc shares in Q3 2019, an estimated $1.47M.
Ardsley Advisory Partners first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 5 quarters.
Ardsley Advisory Partners's T2 Biosystems, Inc position peaked at $6.97M in Q3 2018.
48 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2019.

Based on Ardsley Advisory Partners's 13F filing for Q3 2019, filed 14 Nov 2019.